メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
櫻井 香
予防医療センター
ウェブサイト
https://k-ris.keio.ac.jp/html/100002658_ja.html
h-index
126
被引用数
7
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2018
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(22)
類似のプロファイル
(6)
フィンガープリント
Kaori Sakuraiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
COVID-19
82%
Odds Ratio
30%
Computer Assisted Tomography
22%
Cigarette Smoke
20%
Pathophysiology
20%
Bone Density
19%
Biological Marker
19%
Cohort Analysis
19%
Anemia
18%
Echocardiography
18%
Pulmonary Hypertension
18%
Emphysema
16%
Retrospective Cohort Study
16%
Kidney Function
16%
P Wave
16%
Symptom
16%
Fatty Acid Oxidation
16%
Cohort Study
16%
Lymphocyte
16%
Chronic Kidney Disease
16%
Blood Pressure
16%
Alveolar Type II Cells
16%
Baricitinib
16%
Neutrophil
16%
Ferritin
16%
Passive Smoking
16%
Artificial Respiration
15%
St. George Respiratory Questionnaire
13%
Migraine
12%
Lung Function
11%
Quality of Life
8%
Stem Cell
8%
Migraine with Aura
8%
Mortality Rate
6%
Bisphosphonate
5%
Total Lung Capacity
5%
Lung Adenoma
5%
Keyphrases
COVID-19
34%
Patients with COVID-19
19%
Japan
18%
Japanese Patients
18%
COVID-19 Severity
18%
Odds Ratio
17%
Bone Mineral Density
16%
Modifying Factors
16%
Cigarette Smoke Exposure
16%
Impaired Renal Function
16%
Pre-existing Hypertension
16%
Pulmonary Hypertension
16%
Propensity Score Analysis
16%
Long COVID
16%
ABO Blood Group
16%
Cigarette Smoking
16%
Fat-free Mass Index
16%
Observational Cohort Study
16%
Predictive Factors
16%
Genotype
16%
Chronic Kidney Disease
16%
Baricitinib
16%
Alveolar Type II Cells
16%
Echocardiography
16%
Fatty Acid Oxidation
16%
Cell Stemness
16%
Lower Respiratory Symptoms
16%
Matched Cohort Study
16%
Prognostic Significance
16%
P-wave Axis
16%
Japanese Population
16%
Chronic Obstructive Pulmonary Disease Patient
16%
Krebs Von Den Lungen-6 (KL-6)
16%
Serum Ferritin
16%
Longitudinal Clinical Data
16%
Invasive Mechanical Ventilation
14%
Chronic Obstructive Pulmonary Disease
10%
Confidence Interval
9%
Rapid Decliners
9%
Respiratory Outcomes
8%
Ferritin
8%
Intermittent Smoking
8%
Vertical P-wave Axis
7%
Severe Disease
6%
Stem Cells
6%
Adjusted Odds Ratio
6%
Comorbidity
5%
Lung Adenoma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
55%
Cohort Study
34%
Coronavirinae
33%
Disease
33%
Cigarette Smoke
26%
Biological Marker
22%
Pathophysiology
22%
Pulmonary Hypertension
18%
Symptom
16%
Prospective Cohort Study
16%
Fatty Acid
16%
Ferritin
16%
Baricitinib
16%
Mucin 1
16%
Migraine
16%
Intestine Flora
16%
Short Chain Fatty Acid
16%
Anemia
16%
Lung Tumor
16%
Cyclooxygenase 2
16%
Prostaglandin E2
16%
Celecoxib
16%
Emphysema
16%
Migraine with Aura
11%
Inflammation
9%
Mouse Model
8%
Lung Carcinoma
8%
Mouse
7%
Comorbidity
7%
Lung Cancer
6%
Headache
5%
Potassium Chloride
5%
C57BL 6 Mouse
5%
Isoflurane
5%
SARS Coronavirus
5%
Lung Adenoma
5%
COX-2 Inhibitor
5%
